Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NM › Silver City › NPI 1336220839
Hospital

Gila Regional Medical Center

Gila Regional Medical Center was paid $33.33M by Medicaid between Jan 2018 and Dec 2024, across 213 billing codes. Its largest line is 99284, emergency room visit (serious) — 12% of everything it billed.

33Billing provider infoGILA REGIONAL MEDICAL CENTER
SILVER CITY, NM 88061
33aNPI1336220839assigned 10/18/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$33.33M
24GClaims498,911
24DCodes billed213
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Mexico

Rank by total paid#8 of 24
Median peer was paid$20.13M
This provider vs. median1.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201885,127$3.40M
201968,771$3.08M
202061,371$3.18M
202156,529$3.99M
202270,375$6.13M
202390,777$7.58M
2024incomplete65,961$5.98M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 14,802 13,272 $3.92M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 16,462 15,283 $3.66M
74177 Computed tomography, abdomen and pelvis; with contrast material 6.2% 3,193 2,907 $2.07M
A0427 Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 5.4% 7,058 5,616 $1.80M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.1% 3,462 3,171 $1.36M
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.7% 7,765 7,282 $1.24M
70450 Computed tomography, head or brain; without contrast material 3.4% 3,392 3,027 $1.12M
A0425 Ground mileage, per statute mile 3.3% 12,314 8,950 $1.10M
A0429 Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) 2.9% 3,626 2,880 $975K
80053 Comprehensive metabolic panel 2.7% 30,371 25,524 $895K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2.7% 3,412 3,300 $890K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.5% 10,222 8,614 $822K
201 more codes
G0378 Hospital observation service, per hour 2.3% 1,261 $778K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.1% 6,189 $703K
96375 Therapeutic injection; each additional sequential IV push 2.1% 10,272 $694K
71045 Radiologic examination, chest; single view 1.8% 7,906 $585K
96361 Intravenous infusion, hydration; each additional hour 1.7% 9,091 $575K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.5% 6,227 $510K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.5% 9,137 $497K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.4% 909 $478K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.3% 3,768 $441K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 925 $423K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 31,436 $422K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,069 $329K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,306 $302K
71275 Computed tomographic angiography, chest, with contrast material <1% 458 $291K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 560 $273K
72125 Computed tomography, cervical spine; without contrast material <1% 654 $262K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,778 $261K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 2,579 $246K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 372 $246K
71046 Radiologic examination, chest; 2 views <1% 2,868 $211K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,629 $209K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,352 $201K
36415 Collection of venous blood by venipuncture <1% 42,698 $193K
80306 <1% 4,997 $166K
84484 <1% 6,779 $159K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 1,280 $153K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 25,285 $153K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,461 $153K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,238 $140K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 293 $127K
J3490 Unclassified drugs <1% 15,026 $122K
88313 <1% 2,331 $118K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,484 $110K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,726 $102K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 254 $93K
73630 <1% 750 $85K
83690 <1% 5,262 $85K
73610 <1% 585 $83K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,245 $76K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,917 $71K
73130 <1% 520 $70K
86900 <1% 1,571 $69K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 213 $67K
83605 <1% 4,931 $65K
81001 <1% 7,202 $64K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 185 $61K
80048 Basic metabolic panel (calcium, ionized) <1% 2,756 $58K
77063 Screening digital breast tomosynthesis, bilateral <1% 457 $57K
J7050 Infusion, normal saline solution, 250 cc <1% 2,313 $56K
84443 Thyroid stimulating hormone (TSH) <1% 2,659 $55K
84703 <1% 3,220 $55K
83880 <1% 1,922 $54K
A4649 Surgical supply; miscellaneous <1% 1,800 $51K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,144 $50K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 3,090 $46K
73030 <1% 326 $44K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,129 $44K
71250 <1% 122 $43K
87040 <1% 1,987 $43K
85379 <1% 1,378 $42K
96376 <1% 2,131 $38K
85027 <1% 3,444 $37K
J7030 Infusion, normal saline solution , 1000 cc <1% 9,104 $37K
J2704 Injection, propofol, 10 mg <1% 5,019 $35K
84702 <1% 1,686 $35K
83735 <1% 2,692 $35K
36591 <1% 430 $31K
97113 <1% 298 $30K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 25 $29K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 206 $29K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,901 $29K
96367 <1% 651 $29K
73560 <1% 333 $28K
59025 Fetal non-stress test <1% 327 $28K
85610 <1% 3,819 $28K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 610 $27K
87081 <1% 1,856 $25K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 3,393 $25K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 7,735 $23K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 122 $23K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 5,472 $23K
82948 <1% 3,659 $22K
73110 <1% 199 $22K
86850 <1% 1,390 $21K
76642 <1% 137 $21K
81003 <1% 3,999 $21K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 141 $20K
76536 <1% 119 $20K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,623 $19K
88342 <1% 448 $18K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 283 $17K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 488 $17K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 5,471 $17K
88312 <1% 205 $16K
81025 <1% 1,230 $16K
97162 <1% 212 $15K
80143 <1% 370 $15K
93971 <1% 122 $12K
80061 Lipid panel <1% 698 $12K
86901 <1% 1,576 $12K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 25 $11K
87486 <1% 254 $10K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,598 $10K
90715 <1% 374 $10K
72100 <1% 101 $9K
85730 <1% 989 $9K
83036 Hemoglobin; glycosylated (A1C) <1% 949 $9K
80179 <1% 338 $9K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,143 $9K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,720 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,804 $8K
87581 <1% 254 $8K
87186 <1% 440 $8K
82805 <1% 140 $7K
12001 <1% 37 $7K
62323 <1% 33 $7K
70486 <1% 14 $7K
84439 <1% 458 $6K
76770 <1% 31 $6K
80299 <1% 250 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 137 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,357 $6K
94760 <1% 788 $6K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 1,871 $5K
76641 <1% 25 $5K
J2060 Injection, lorazepam, 2 mg <1% 1,746 $5K
80081 <1% 68 $5K
85652 <1% 686 $5K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,959 $5K
86141 <1% 249 $5K
76830 Ultrasound, transvaginal <1% 27 $5K
94799 <1% 28 $4K
74022 <1% 65 $4K
87070 <1% 312 $4K
82550 <1% 302 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 122 $4K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 122 $4K
73562 <1% 28 $4K
36600 <1% 116 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,115 $3K
51702 <1% 45 $3K
74019 <1% 12 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 33 $3K
87807 <1% 166 $2K
73090 <1% 14 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 482 $2K
96523 <1% 64 $2K
J3480 Injection, potassium chloride, per 2 meq <1% 286 $2K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 3,424 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 426 $2K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 60 $2K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 176 $2K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 67 $2K
74018 <1% 36 $2K
73502 <1% 26 $1K
83540 <1% 122 $1K
77065 Tomosynthesis, mammo <1% 13 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 208 $1K
83550 <1% 70 $1K
82728 <1% 42 $1K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 39 $1K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 28 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 193 $905.92
87481 <1% 20 $787.24
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 29 $735.55
J9303 Injection, panitumumab, 10 mg <1% 19 $679.52
86592 <1% 99 $651.53
87077 <1% 68 $647.88
88302 <1% 31 $638.75
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 42 $612.40
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 102 $525.76
J0561 Injection, penicillin g benzathine, 100,000 units <1% 15 $522.19
84550 <1% 39 $510.55
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 50 $506.60
J3475 Injection, magnesium sulfate, per 500 mg <1% 135 $478.55
82565 <1% 98 $439.06
84100 <1% 38 $417.79
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 18 $393.58
86140 <1% 39 $345.28
97161 <1% 12 $335.26
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) <1% 28 $295.09
87660 <1% 16 $276.36
87510 <1% 16 $276.36
87480 <1% 16 $274.91
82947 <1% 43 $245.73
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 42 $243.64
J2550 Injection, promethazine hcl, up to 50 mg <1% 233 $219.40
A9270 Non-covered item or service <1% 47 $155.86
83615 <1% 12 $155.58
J1815 Injection, insulin, per 5 units <1% 88 $152.05
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 89 $129.44
C1758 Catheter, ureteral <1% 15 $103.03
J1630 Injection, haloperidol, up to 5 mg <1% 18 $98.73
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 172 $84.16
85008 <1% 14 $71.83
87147 <1% 14 $68.88
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 16 $55.54
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 43 $38.96
J8540 Dexamethasone, oral, 0.25 mg <1% 12 $32.31
S5001 Prescription drug, brand name <1% 18 $17.03
99214 Doctor's office visit, returning patient (more involved) 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWHITAKER, ROBERT (CEO)